Q-PHARM

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	28-07-2025	3 d early	2025-00349542
31-12-2022	31-07-2023	30-08-2023	30 d late	2023-00422519

Metric	This company	Sector median	Position in the sector
Solvency	67.4%	60.5%	better than 59% of 12487 sector peers
Net result	€22k	€31k	better than 41% of 12489 sector peers
Equity	€73k	€63k	better than 55% of 12495 sector peers
Gross operating margin	€28k	€52k	better than 32% of 12474 sector peers
Total assets	€108k	€124k	better than 45% of 12488 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€108k
Fixed assets	21/28	€1k
Tangible fixed assets	22/27	€1k
Current assets	29/58	€107k
Amounts receivable within one year	40/41	€44k
Cash & bank	54/58	€45k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€108k
Equity	10/15	€73k
Contributions / capital	10/11	€1k
Reserves	13	€49k
Accumulated profits (losses)	14	€23k
Amounts payable	17/49	€35k
Amounts payable within one year	42/48	€35k
Trade debts payable within one year	44	€11k
Income statement
Gross operating margin	9900	€28k
Operating result	9901	€27k
Financial income	75	€0
Financial charges	65	€50
Result before taxes	9903	€27k
Income taxes	67/77	€6k
Net result for the period	9904	€22k
Result to be appropriated	9905	€22k

Summary